$1.57 Billion is the total value of Eversept Partners, LP's 107 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GSK | GLAXOSMITHKLINE PLCcall | $66,313,170 | +15.4% | 1,503,700 | 0.0% | 4.24% | +6.2% | |
| MGLN | MAGELLAN HEALTH INC | $9,945,453 | +0.5% | 104,700 | 0.0% | 0.64% | -7.6% | |
| TEVA | TEVA PHARMACEUTICAL INDS LTDcall | $7,708,824 | -17.8% | 962,400 | 0.0% | 0.49% | -24.4% | |
| HZNP | HORIZON THERAPEUTICS PUB Lcall | $7,543,200 | -1.6% | 70,000 | 0.0% | 0.48% | -9.4% | |
| MRK | MERCK & CO INCcall | $3,732,368 | +2.0% | 48,700 | 0.0% | 0.24% | -6.3% | |
| DXCM | DEXCOM INC | $3,437,017 | -1.8% | 6,401 | 0.0% | 0.22% | -9.5% | |
| MYO | MYOMO INC | $1,026,750 | -42.4% | 150,000 | 0.0% | 0.07% | -46.8% | |
| ENSG | ENSIGN GROUP INC | $873,504 | +12.1% | 10,397 | 0.0% | 0.06% | +3.7% | |
| HSKA | HESKA CORP | $825,767 | -29.4% | 4,525 | 0.0% | 0.05% | -34.6% | |
| CYCN | CYCLERION THERAPEUTICS INC | $639,763 | -44.0% | 371,955 | 0.0% | 0.04% | -48.1% | |
| ELDN | ELEDON PHARMACEUTICALS INC | $502,775 | -28.6% | 114,008 | 0.0% | 0.03% | -34.7% | |
| FSTX | F-STAR THERAPEUTICS INC | $250,664 | -31.4% | 49,933 | 0.0% | 0.02% | -36.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.